Translational Development Acquisition TDACU
NASDAQ TDACU
$11.48 +0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST

Translational Development Acquisition (TDACU) Preferred Stock Liabilities (2024 - 2026)

Updated

Translational Development Acquisition's Preferred Stock Liabilities came in at $157.26 million for Q2 2026, down 11.7% from $178.03 million a year earlier and down 14.2% from the prior quarter.

Analysis

Translational Development Acquisition (TDACU) Preferred Stock Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Translational Development Acquisition's Preferred Stock Liabilities was $181.66 million, up 4.2% from FY2024.

  • Going back by year, Preferred Stock Liabilities was $174.35 million in FY2024.
  • Business Quant data shows TDACU's Preferred Stock Liabilities at $183.27 million (Q1 2026), $181.66 million (Q4 2025) and $179.9 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 157.26 Mn
Mar 31, 2026 183.27 Mn
Dec 31, 2025 181.66 Mn
Sep 30, 2025 179.90 Mn
Jun 30, 2025 178.03 Mn
Mar 31, 2025 176.18 Mn
Dec 31, 2024 174.35 Mn
API Access

Translational Development Acquisition Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=TDACU&period=max&api_key=YOUR_API_KEY